孚能科技(688567.SH):擬建設贛州年產30GWh新能源電池項目
格隆匯8月1日丨孚能科技(688567.SH)公佈,公司擬與贛州經濟技術開發區管理委員會(以下合稱“雙方”)簽訂《投資合作意向協議書》。雙方就孚能科技贛州年產30GWh新能源電池項目相關條款達成一致。
項目分為兩期。其中,一期規劃建設18GWh新能源電池項目。一期項目公司初步規劃為生產三元軟包動力電池產品;二期規劃建設12GWh新能源電池項目。二期擬生產的具體產品類型,公司將根據市場情況及客户訂單情況確定。此次公司先啟動一期18GWh新能源電池項目,後續將根據一期項目建設情況、客户訂單情況、資金安排情況等適時啟動二期12GWh新能源電池項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.